Research and Development (R&D) stories
A new study reveals the conditions that draw people to intervene in cyberbullying, with anonymity reducing the likelihood of intervention.
Wireless automation in industrial processes set to grow at 16.19% over next 5 years, says Research and Markets.
Overall, organisations are displaying a lack of maturity and an over reliance on prevention when it comes to cybersecurity, according to EMC.
Healthcare system software developer Orion Health reported a $60.8 million loss in line with its strategy to grow revenues before becoming profitable.
Data warehousing and big data gurus WhereScape has today announced it has opened its Wellington office this week.
Trends Publishing International chairman David Johnson says he can't comment on specific allegations following the suspension of a three-year resea.
New Zealand IT sector. which has historically struggled to recruit top talent, is in good shape to recruit new employees.
The board of the country's national educational research organisation has appointed Graeme Cosslett to the role of director and chief executive.
Steven Joyce, Science and Innovation Minister, has announced an $80 million boost for R&D funding in New Zealand as part of the Budget 2015.
The government will pump an extra $20 million a year into the research and development Growth Grants programme, one of three types of grant administer.
Labour's finance spokesman Grant Robertson said Labour would look to boost its policy on research and development tax credits because the current gove.
Fisher & Paykel Appliances narrowed its full-year loss in 2014 after sales growth across all its markets helped drive a surge in revenue.
Fisher & Paykel Appliances, the Auckland-based manufacturer and consumer credit company owned by China's Haier Group, narrowed its full-year loss in 2.
Milmeq, which designs, engineers and manufactures systems for primary food processing, has doubled export revenue in the past two years.
Emulex Corporation is continuing to invest in New Zealand's education sector and develop its next generation of engineering talent.
Rex Bionics Plc, the New Zealand company listed on the London Stock Exchange's AIM market, said higher costs to commercialise its robotic exoskeletons.
Douglas Pharmaceuticals, New Zealand's largest developer and manufacturer of generic pharmaceuticals, is targeting annual revenues of $244 million.
MYOB has announced it now has 500,000 regular paying clients, and says its cloud offerings have significantly contributed to this figure.
Rex Bionics, the New Zealand company listed on the London Stock Exchange's growth-orientated AIM market, almost halved in value last week after it.
GeoOp, the small business app developer, widened its first-half loss as it spent more on product development and sales to chase global growth.